ACG

Our comprehensive portfolio comprises specialty packaging films, high-barrier films, and anticounterfeiting and polymer films of pharmaceutical grade. Controlling the entire manufacturing process – from PVC resin stage all the way through to calendering
and slitting – ensures consistent quality and tr...

All ACG cold-form base foils are made only from validated raw material sources and are compliant to global pharmaceutical regulatory standards. Our lidding foils (suitable for both thermo-forming and cold-forming blister packs) match global benchmarks in quality and compliance and exhibit exceptional s...

ACG Associated Capsules Pvt Ltd provides wide range of capsules includes brandshield 360 capsules. It is a circular oriented, two-color printing of the capsule. Contact us for more information.

ACG Associated Capsules Pvt Ltd provides wide range of capsules includes brandshield 4c capsules. It is hard capsules that feature four-color circular oriented printing. With brandshield 4c capsules can imprint brand logo, brand name and graphics right on the capsule, providing exceptional brand awareness....

ACG Associated Capsules Pvt Ltd provides wide range of capsules includes clinicaps capsules. It is two-piece gelatin capsules that are specially designed to carry out 'double blind' studies during clinical trials. After closure (locking), the elongated cap closes tightly on the body, keeping only the dome ...

The pharmaceutical industry has witnessed many positive developments in the last year, including 32 novel drug approvals to date, a bivalent COVID-19 vaccine, and the return of face-to-face events. However, 2022 has also presented the pharma market with new geopolitical challenges. Events such as the war in Ukraine, rising inflation, and increased energy costs have put lasting pressures on manufacturing; the effects of which are still being felt across the sector. Heading into 2023, there is an ongoing focus on the lasting impact of supply chain disruptions, and the rising costs of energy and raw materials. Sustainability also remains a mainstay in the discussion of modernising development, manufacturing, packaging, and transport practices for the pharmaceutical industry. On a positive note, innovation continues to be at the forefront of the industry, with pharmaceutical start-ups and biotechs in particular expected to bring new products, technologies and services to the traditional pharma supply chain. While 2022 has not made the transition into a new year easy, the pharmaceutical industry is in an exciting position to demonstrate its innovation, modernisation, and technological breakthroughs. ACG is proud to bring to you CPHI’s Trend Outlook for 2023, which gathers expert opinion and insights from across the pharma value chain, highlighting both emerging and continuing trends for 2023. As we enter a post-pandemic world and face new global challenges, the pharma industry must be applauded for its pursuit of new products, technologies and solutions which ultimately improve the lives of people worldwide. Read on to discover expert predictions on the trends, opportunities and challenges defining the pharma market in 2023.